What subject line works for Pharmaceuticals referral request emails (replied then went silent)?

Name the situation and the business object, not your excitement. Something like "Forwardable blurb inside, if you're open to an intro" outperforms "Just checking in" because a founder can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

Should I offer a referral fee in the email?

Only if that's already how you work and it won't make them look mercenary. Many operators prefer a clean intro. If you do mention a fee, keep it secondary to why the intro helps the other person. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Why do prospects reply once and then disappear?

Often they needed to check with someone, a fire started, or your last ask was bigger than they meant to take on. A good follow-up shrinks the next step and references what they already said so they don't have to reload context.

Is it okay to send this referral request on LinkedIn instead of email?

Yes if this founder is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · Founder · Replied Then Silent

Referral Request for Pharmaceuticals Founder: Replied Then…

A referral request email asks someone to make an intro by doing the work for them: who, why, and a forwardable blurb. For Pharmaceuticals teams, the version that works for replied then went silent has to respect Don't invent clinical claims. Write to the founder like they already have a full calendar and a reason to be cautious.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this referral request work for a Pharmaceuticals Founder?

Explain why they'd look good for making the intro.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a founder actually reads: Short, vivid, one proof point max.
Quote their last sentence and answer it. People reply to their own unfinished thought.
Include a forwardable paragraph.

When should I send this to a Pharmaceuticals Founder?

Ask after you've given them a reason to want to help, not after the first coffee. Give it a week unless they named a date. Then write on that date, not the day after you got impatient. For this combo, treat "5-7 days, or the date they named" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a founder, Short, vivid, one proof point max.

What this Founder actually cares about

A founder in Pharmaceuticals is protecting runway, focus, and the company's early reputation. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. The hook that earns a look is a problem they personally still own because the team is small. The ask should stay at this size: a yes/no on timing, or a 15-minute working chat. Delete trigger: Calling them a 'decision maker' or pitching like they're a Fortune 500 process. a problem they personally still own because the team is small

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. If you cannot name a label update, a launch window, or a congress, wait until you can. If you cannot name a label update, a launch window, or a congress, wait until you can.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone human and specific.
Never send a referral ask from a brand-new relationship.
Time it for 5-7 days, or the date they named. Give it a week unless they named a date. Then write on that date, not the day after you got impatient.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this replied then silent note?

Asking 'who do you know?' is lazy and gets no names.
Don't forward the whole thread with 'friendly bump' and nothing else.
Don't use consumer-startup slang. It's a credibility leak.
Calling them a 'decision maker' or pitching like they're a Fortune 500 process.

How does this replied then silent scenario compare?

Dimension	For this template
Best send window	5-7 days, or the date they named
Ideal length	Short, vivid, one proof point max.
Primary ask	a yes/no on timing, or a 15-minute working chat
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Human and specific. Peer to peer, not vendor to 'target.'
Unlike no response	They already spent social energy. Treat them like a conversation, not a lead.
Unlike after proposal	You may not have a document on the table yet. Don't invent a buying process.

What should I copy and send?

Copy-ready template

Subject

Forwardable blurb inside, if you're open to an intro

Body

Hi [First Name],

If you're willing, I wrote a blurb you can forward as-is.

In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. If now is a bad time, don't spend political capital on this.

Given this is replied then went silent, ask if the blocker is timing, people, or the work itself.

Thanks either way. I know intros cost you something.

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Some do, usually the ones that feel written to their company this week. If you cite a real trigger and keep the ask small, you have a chance. If you mail-merge 'loved your journey,' you don't. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Related templates

Want a custom draft instead? Try the email generator.